CLOSED
NIFTY 5022,453.30+0.98%SENSEX74,235.62+1.24%BANK NIFTY48,892.15+1.45%NIFTY IT35,124.80-0.52%NIFTY MIDCAP52,487.25+0.87%NIFTY 5022,453.30+0.98%SENSEX74,235.62+1.24%BANK NIFTY48,892.15+1.45%NIFTY IT35,124.80-0.52%NIFTY MIDCAP52,487.25+0.87%
FTFranklin Templeton MFGrowth

Franklin Pharma Fund - Growth

Pharma & Health CareEquity - Sectoral Fund - Pharma & Health CareBenchmark: ET Pharma
NAV · 09 Sep 2011₹61.62-0.40%
AUM₹134 Cr
Expense Ratio2.06%
CAGR—
Exit Load1% on or before 1Y
Min SIP₹500
Launched1999

Investment Objective

The scheme seeks to provide long-term capital appreciation by investing primarily in Pharmaceutical stocks, biotechnology and agrochemicals with high profit potential.

Fund Mandate

Debt0%–35%
Equity65%–100%
MMI0%–35%
Others0%–35%
Asset Allocation
Domestic Equity79.8%
Debt0.2%
Cash & Equivalents20.0%
Fund Managers
AR
Anand Radhakrishnan
Fund Manager
Key Information
2.06%
₹500
₹5,000
1% on or before 1Y
Nil
Inception31 Mar 1999
AMCFranklin Templeton MF
Top Holdings
1Call, Cash & Other Current Assets Others19.99%
2Zydus Lifesciences Ltd.Healthcare10.63%
3Dr. Reddy's Laboratories Ltd.Healthcare9.04%
4Lupin Ltd.Healthcare8.57%
5Ipca Laboratories Ltd.Healthcare7.04%
6Pfizer Ltd.Healthcare6.68%
7Wyeth Ltd.- (Amalgamated)Healthcare6.33%
8Torrent Pharmaceuticals Ltd.Healthcare5.82%
9Sun Pharmaceutical Industries Ltd.Healthcare5.49%
10Apollo Hospitals Enterprise Ltd.Healthcare4.59%
Sector Allocation
Healthcare75.2%
Others20.0%
FMCG3.9%
Trading0.8%
On This Page
NAV growthAsset allocationTop holdings
Similar Funds
TRUSTMF Small Cap Fund - IDCW - Direct PlanTrust MF+27.43%TRUSTMF Small Cap Fund - Growth - Direct PlanTrust MF+27.33%TRUSTMF Small Cap Fund - Regular Plan - GrowthTrust MF+25.38%TRUSTMF Small Cap Fund - Regular Plan - IDCWTrust MF+25.38%Kotak Healthcare Fund - IDCW - Direct PlanKotak MF+25.27%
Compare With

TRUSTMF Small Cap Fund - IDCW - Direct Plan and 4 more peers in this category.

Build comparison
Trailing Returns
PeriodReturns
1 Day-0.40%
Risk Metrics

Risk metrics are not available for this fund.

Fees
2.06%
1% on or before 1Y
Nil
₹500
₹5,000
Capital Gains Tax, general rules

This is an equity-oriented fund. Under rules effective since Budget 2024 (23 July 2024):

Short-Term Capital Gains (held ≤ 12 months): taxed at a flat 20%.

Long-Term Capital Gains (held > 12 months): taxed at 12.5% on gains above ₹1.25 lakh in a financial year, with no indexation benefit.

General information only, not tax advice, actual liability depends on your overall income and applicable law at the time of redemption. Consult a tax advisor for your specific situation.

Frequently Asked QuestionsGeneral mutual-fund FAQs, not specific to this scheme